Thomas Jefferson University

Thorir Bjornsson

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address1025 Walnut St.
Philadelphia PA 19107
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01HL043183     (BJORNSSON, THORIR D)Jul 1, 1990 - Feb 28, 1994
    NIH
    ASPIRIN'S FIBRINOLYTIC EFFECT--ACETYLATION OF FIBRINOGEN
    Role: Principal Investigator
    R01HL045593     (BJORNSSON, THORIR D)Jan 5, 1991 - Dec 31, 1996
    NIH
    PHARMACOLOGY OF ENDOTHELIAL CELL TPA/UPA SYNTHESIS
    Role: Principal Investigator
    T32GM008562     (KRAFT, WALTER K)Jul 1, 1995 - Jun 30, 2030
    NIH
    Clinical Pharmacology Training Program
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Darpo B, Bjornsson TD, Brathwaite WA, Crincoli CM, Eapen AK, Fisher GL, Kowey PR, Miller MP, Nikiforov AI, Rihner MO, Zhou M. Detection of ECG effects of (2R,4R)-monatin, a sweet flavored isomer of a component first identified in the root bark of the Sclerochitin ilicifolius plant. Food Chem Toxicol. 2016 May; 91:217-24. PMID: 26747976.
      Citations:    
    2. Zhou SY, Shu C, Korth-Bradley J, Raible D, Palmisano M, Wadjula J, Fatenejad S, Bjornsson T. Integrated population pharmacokinetics of etanercept in healthy subjects and in patients with rheumatoid arthritis and ankylosing spondylitis. J Clin Pharmacol. 2011 Jun; 51(6):864-75. PMID: 20852002.
      Citations:    
    3. Jacobsen JS, Comery TA, Martone RL, Elokdah H, Crandall DL, Oganesian A, Aschmies S, Kirksey Y, Gonzales C, Xu J, Zhou H, Atchison K, Wagner E, Zaleska MM, Das I, Arias RL, Bard J, Riddell D, Gardell SJ, Abou-Gharbia M, Robichaud A, Magolda R, Vlasuk GP, Bjornsson T, Reinhart PH, Pangalos MN. Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A. 2008 Jun 24; 105(25):8754-9. PMID: 18559859.
      Citations:    
    4. Grasela TH, Dement CW, Kolterman OG, Fineman MS, Grasela DM, Honig P, Antal EJ, Bjornsson TD, Loh E. Pharmacometrics and the transition to model-based development. Clin Pharmacol Ther. 2007 Aug; 82(2):137-42. PMID: 17632539.
      Citations:    
    5. Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, Murphy WR, Roman K, Schneck D, Sonnichsen DS, Stalker DJ, Wise SD, Dombey S, Loew C. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol. 2003 Sep; 43(9):943-67. PMID: 12971027.
      Citations:    
    6. Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach RS, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos. 2003 Jul; 31(7):815-32. PMID: 12814957.
      Citations:    
    7. Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective. J Clin Pharmacol. 2003 May; 43(5):443-69. PMID: 12751267.
      Citations:    
    8. Greenberg HE, Wissel P, Barrett J, Barchowsky A, Gould R, Farrell D, Panebianco D, Hand E, Gillen L, Goldberg MR, Bjornsson TD. Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers. J Clin Pharmacol. 2000 May; 40(5):496-507. PMID: 10806603.
      Citations:    
    9. McCrea JB, Cribb A, Rushmore T, Osborne B, Gillen L, Lo MW, Waldman S, Bjornsson T, Spielberg S, Goldberg MR. Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174. Clin Pharmacol Ther. 1999 Mar; 65(3):348-52. PMID: 10096267.
      Citations:    
    10. Zhang W, Johnson BR, Suri DE, Martinez J, Bjornsson TD. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques. Acta Neuropathol. 1998 Oct; 96(4):395-400. PMID: 9797004.
      Citations:    
    11. Bjornsson TD, Troetel WM, Imbimbo BP. Effect of food on the absorption of eptastigmine. Eur J Clin Pharmacol. 1998 May; 54(3):243-7. PMID: 9681667.
      Citations:    
    12. Greenberg HE, England MJ, Hellriegel ET, Bjornsson TD. Time of peak drug concentration after a single dose and a dose at steady state. J Clin Pharmacol. 1997 Jun; 37(6):480-5. PMID: 9208354.
      Citations:    
    13. Zhang W, Johnson BR, Bjornsson TD. Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide. Life Sci. 1997; 60(25):2323-32. PMID: 9194688.
      Citations:    
    14. Bjornsson TD. Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations. Eur J Drug Metab Pharmacokinet. 1997 Jan-Mar; 22(1):1-14. PMID: 9179555.
      Citations:    
    15. Hellriegel ET, Bjornsson TD, Hauck WW. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clin Pharmacol Ther. 1996 Dec; 60(6):601-7. PMID: 8988062.
      Citations:    
    16. Bjornsson TD. A classification of drug action based on therapeutic effects. J Clin Pharmacol. 1996 Aug; 36(8):669-73. PMID: 8877669.
      Citations:    
    17. Waldman SA, Vitow C, Osborne B, Gillen L, Argentieri DC, Wong FA, Smith IL, Chow AT, Misiti J, Bjornsson TD. Pharmacokinetics and pharmacodynamics of tepoxalin after single oral dose administration to healthy volunteers. J Clin Pharmacol. 1996 May; 36(5):462-8. PMID: 8739025.
      Citations:    
    18. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther. 1995 Dec; 58(6):641-9. PMID: 8529329.
      Citations:    
    19. Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol. 1995 Oct; 35(10):1008-15. PMID: 8568008.
      Citations:    
    20. Sobel MI, Winkel CA, Macy LB, Liao P, Bjornsson TD. The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):801-8. PMID: 7573247.
      Citations:    
    21. Schwartz JI, Yeh KC, Berger ML, Tomasko L, Hoover ME, Ebel DL, Stauffer LA, Han R, Bjornsson TD. Novel oral medication delivery system for famotidine. J Clin Pharmacol. 1995 Apr; 35(4):362-7. PMID: 7650224.
      Citations:    
    22. Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G, et al. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension. 1995 Jan; 25(1):37-46. PMID: 7843751.
      Citations:    
    23. Bjornsson TD, Lui NL, England MJ. Estimation of pharmacokinetic parameters for simulations of time courses of drug concentrations after oral administration. J Clin Pharmacol. 1994 Nov; 34(11):1046-52. PMID: 7876394.
      Citations:    
    24. Schwartz JI, Margolskee DJ, Bjornsson TD, Williams VC, Hsieh JY, Lin CC, Rogers JD. Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast. Br J Clin Pharmacol. 1993 Nov; 36(5):464-6. PMID: 12959296.
      Citations:    
    25. McCrea JB, Fruncillo RJ, Holland SD, Conroy JA, Shingo S, Spector R, Bjornsson TD. Lovastatin does not affect oral glucose tolerance in hypercholesterolemic patients. J Clin Pharmacol. 1993 Jun; 33(6):581-5. PMID: 8366184.
      Citations:    
    26. Goldberg MR, Tanaka W, Barchowsky A, Bradstreet TE, McCrea J, Lo MW, McWilliams EJ, Bjornsson TD. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension. 1993 May; 21(5):704-13. PMID: 8491505.
      Citations:    
    27. Korner G, Bjornsson TD, Vlodavsky I. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. J Cell Physiol. 1993 Mar; 154(3):456-65. PMID: 8436596.
      Citations:    
    28. Kuo BS, Bjornsson TD. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay. Anal Biochem. 1993 Feb 15; 209(1):70-8. PMID: 8465964.
      Citations:    
    29. Kong AN, Yang L, Ma M, Tao D, Bjornsson TD. Molecular cloning of the alcohol/hydroxysteroid form (hSTa) of sulfotransferase from human liver. Biochem Biophys Res Commun. 1992 Aug 31; 187(1):448-54. PMID: 1520333.
      Citations:    
    30. Bjornsson TD. The method of relative drug accumulation: a simple method for illustrating the effects of different drug dosing regimens and variability in drug elimination on time courses of drug concentrations. Clin Pharmacol Ther. 1992 Mar; 51(3):266-70. PMID: 1544286.
      Citations:    
    31. Shi Y, Nardone D, Hernandez-Martinez A, Walinsky P, Bjornsson TD, Zalewski A. Fibrinolytic activity after vessel wall injury. J Am Coll Cardiol. 1992 Feb; 19(2):441-3. PMID: 1531060.
      Citations:    
    32. Bjornsson TD. Two steady-state pharmacokinetic parameters: peak-to-trough drug concentration ratio and time of occurrence of time-averaged concentration. J Pharm Sci. 1992 Jan; 81(1):108-9. PMID: 1619562.
      Citations:    
    33. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991 Oct 01; 88(19):8651-5. PMID: 1717983.
      Citations:    
    34. Zalewski A, Shi Y, Nardone D, Bravette B, Weinstock P, Fischman D, Wilson P, Goldberg S, Levin DC, Bjornsson TD. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates. Circulation. 1991 May; 83(5):1685-91. PMID: 1902406.
      Citations:    
    35. Levitt MA, Dryjski M, Tluczek J, Bjornsson TD. Evaluation of a prostacyclin analog, iloprost, and a thromboxane A2 receptor antagonist, daltroban, in experimental intimal hyperplasia. Prostaglandins. 1991 Jan; 41(1):1-6. PMID: 1708508.
      Citations:    
    36. Rocci ML, Vlasses PH, Distlerath LM, Gregg MH, Wheeler SC, Zing W, Bjornsson TD. Norfloxacin does not alter warfarin's disposition or anticoagulant effect. J Clin Pharmacol. 1990 Aug; 30(8):728-32. PMID: 2401751.
      Citations:    
    37. Flaharty KK, Caro J, Erslev A, Whalen JJ, Morris EM, Bjornsson TD, Vlasses PH. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther. 1990 May; 47(5):557-64. PMID: 2188770.
      Citations:    
    38. Mottow-Lippa LS, Lippa EA, Naidoff MA, Clementi R, Bjornsson T, Jones K. .008% timolol ophthalmic solution. A minimal-effect dose in a normal volunteer model. Arch Ophthalmol. 1990 Jan; 108(1):61-4. PMID: 2404487.
      Citations:    
    39. Gertz BJ, Vlasses PH, Rocci ML, Coker LD, Williams V, Bjornsson TD, Jones KH. Clinical evaluation of a benzofuroquinolizine alpha 2-adrenoceptor antagonist. Clin Pharmacol Ther. 1989 Nov; 46(5):566-75. PMID: 2573444.
      Citations:    
    40. Korner G, Schneider DE, Purdon MA, Bjornsson TD. Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity. Biochem J. 1989 Sep 01; 262(2):633-41. PMID: 2572221.
      Citations:    
    41. Dryjski M, Schneider DE, Mojaverian P, Kuo BS, Bjornsson TD. Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations. Br J Clin Pharmacol. 1989 Aug; 28(2):188-92. PMID: 2550047.
      Citations:    
    42. Bjornsson TD, Schneider DE, Berger H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther. 1989 Jul; 250(1):154-61. PMID: 2746495.
      Citations:    
    43. Kuo BS, Dryjski M, Bjornsson TD. Influence of nicotine and cotinine on the expression of plasminogen activator activity in bovine aortic endothelial cells. Thromb Haemost. 1989 Feb 28; 61(1):70-6. PMID: 2501891.
      Citations:    
    44. German DC, Kredich NM, Bjornsson TD. Oral dipyridamole increases plasma adenosine levels in human beings. Clin Pharmacol Ther. 1989 Jan; 45(1):80-4. PMID: 2910640.
      Citations:    
    45. Dryjski M, Mikat E, Bjornsson TD. Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid. J Vasc Surg. 1988 Nov; 8(5):623-33. PMID: 2460647.
      Citations:    
    46. Dryjski M, Kuo BS, Bjornsson TD. Interaction of thrombin and factor Xa with bovine vascular endothelial cells, smooth muscle cells and rat hepatoma cells. Thromb Haemost. 1988 Oct 31; 60(2):148-52. PMID: 3217915.
      Citations:    
    47. Kuo BS, Korner G, Dryjski M, Bjornsson TD. Role of polyamines in the stimulation of synthesis and secretion of plasminogen activator from bovine aortic endothelial cells. J Cell Physiol. 1988 Oct; 137(1):192-8. PMID: 3139680.
      Citations:    
    48. Bjornsson TD, Schneider DE, Hecht AR. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo disposition. J Pharmacol Exp Ther. 1988 Jun; 245(3):804-8. PMID: 3164387.
      Citations:    
    49. Kuo BS, Korner G, Bjornsson TD. Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cells. J Clin Invest. 1988 Mar; 81(3):730-7. PMID: 3125227.
      Citations:    
    50. Grierson DS, Bjornsson TD. Pharmacokinetics of streptokinase in patients based on amidolytic activator complex activity. Clin Pharmacol Ther. 1987 Mar; 41(3):304-13. PMID: 3816018.
      Citations:    
    51. Cocchetto DM, Bjornsson TD. Bimodal frequency distribution of rat hepatic vitamin K-dependent carboxylation rate. Life Sci. 1986 Nov 24; 39(21):1977-83. PMID: 3784766.
      Citations:    
    52. Moorman JR, Yee R, Bjornsson T, Starmer CF, Grant AO, Strauss HC. pKa does not predict pH potentiation of sodium channel blockade by lidocaine and W6211 in guinea pig ventricular myocardium. J Pharmacol Exp Ther. 1986 Jul; 238(1):159-66. PMID: 2425074.
      Citations:    
    53. Bjornsson TD, Huang AT, Roth P, Jacob DS, Christenson R. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations. Clin Pharmacol Ther. 1986 Jan; 39(1):25-8. PMID: 3943266.
      Citations:    
    54. Cocchetto DM, Bjornsson TD. Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylation. Haemostasis. 1986; 16(5):321-36. PMID: 3781349.
      Citations:    
    55. Bjornsson TD, Schold SC, Friedman HS, Schneider D, Falletta JM. Pharmacokinetics of diaziquone after three different dosage regimens. Cancer Treat Rep. 1985 Dec; 69(12):1383-5. PMID: 4075314.
      Citations:    
    56. Hanson SR, Harker LA, Bjornsson TD. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest. 1985 May; 75(5):1591-9. PMID: 3923041.
      Citations:    
    57. Smith MS, Benyunes MC, Bjornsson TD, Shand DG, Pritchett EL. Influence of cimetidine on verapamil kinetics and dynamics. Clin Pharmacol Ther. 1984 Oct; 36(4):551-4. PMID: 6478741.
      Citations:    
    58. Nash PV, Bjornsson TD. Determination of plasma heparin by polybrene neutralization. Anal Biochem. 1984 May 01; 138(2):319-23. PMID: 6742408.
      Citations:    
    59. Schold SC, Friedman HS, Bjornsson TD, Falletta JM. Treatment of patients with recurrent primary brain tumors with AZQ. Neurology. 1984 May; 34(5):615-9. PMID: 6538653.
      Citations:    
    60. Ellinwood EH, Easler ME, Linnoila M, Molter DW, Heatherly DG, Bjornsson TD. Effects of oral contraceptives on diazepam-induced psychomotor impairment. Clin Pharmacol Ther. 1984 Mar; 35(3):360-6. PMID: 6697644.
      Citations:    
    61. McGowan FX, Nash PV, Bjornsson TD. Assay-dependent kinetics of heparin: evidence for rapid in vivo activation of heparin. Br J Clin Pharmacol. 1983 Dec; 16(6):677-82. PMID: 6661353.
      Citations:    
    62. Mahony C, Wolfram KM, Nash PV, Bjornsson TD. Kinetics and metabolism of sulfinpyrazone. Clin Pharmacol Ther. 1983 Apr; 33(4):491-7. PMID: 6831828.
      Citations:    
    63. Mahony C, Cox JL, Bjornsson TD. Plasma dipyridamole concentrations after two different dosage regimens in patients. J Clin Pharmacol. 1983 Feb-Mar; 23(2-3):123-6. PMID: 6853744.
      Citations:    
    64. Abou-Donia MB, Kinnes CG, Abdo KM, Bjornsson TD. Physiological disposition and metabolism of O-ethyl-O-4-nitrophenyl phenylphosphonothioate in male cats following a single dermal administration. Drug Metab Dispos. 1983 Jan-Feb; 11(1):31-6. PMID: 6132792.
      Citations:    
    65. Bjornsson TD, Mahony C. Clinical pharmacokinetics of dipyridamole. Thromb Res Suppl. 1983; 4:93-104. PMID: 6579711.
      Citations:    
    66. Cocchetto DM, Bjornsson TD. Simulation: an underutilized approach to coagulation system model evaluation. Thromb Res. 1982 Oct 15; 28(2):223-36. PMID: 7179216.
      Citations:    
    67. Mahony C, Wolfram KM, Cocchetto DM, Bjornsson TD. Dipyridamol kinetics. Clin Pharmacol Ther. 1982 Mar; 31(3):330-8. PMID: 7060316.
      Citations:    
    68. Bjornsson TD, Wolfram KM, Kitchell BB. Heparin kinetics determined by three assay methods. Clin Pharmacol Ther. 1982 Jan; 31(1):104-13. PMID: 7053298.
      Citations:    
    69. Bjornsson TD, Wolfram KM. Intersubject variability in the anticoagulant response to heparin in vitro. Eur J Clin Pharmacol. 1982; 21(6):491-7. PMID: 6176454.
      Citations:    
    70. Brown JE, Kitchell BB, Bjornsson TD, Shand DG. The artifactual nature of heparin-induced drug protein-binding alterations. Clin Pharmacol Ther. 1981 Nov; 30(5):636-43. PMID: 6794969.
      Citations:    
    71. Shand DG, Desjardins RE, Bjornsson TD, Hammill SC, Pritchett EL. The method of separate exponentials: a simple aid to devising intravenous drug-loading regimens. Clin Pharmacol Ther. 1981 Apr; 29(4):542-7. PMID: 7471622.
      Citations:    
    72. Routledge PA, Kitchell BB, Bjornsson TD, Skinner T, Linnoila M, Shand DG. Diazepam and N-desmethyldiazepam redistribution after heparin. Clin Pharmacol Ther. 1980 Apr; 27(4):528-32. PMID: 6766834.
      Citations:    
    73. Routledge PA, Barchowsky A, Bjornsson TD, Kitchell BB, Shand DG. Lidocaine plasma protein binding. Clin Pharmacol Ther. 1980 Mar; 27(3):347-51. PMID: 7357791.
      Citations:    
    74. Bjornsson TD, Meffin PJ, Peters FA, Blaschke TF. Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients. Clin Pharmacol Ther. 1980 Feb; 27(2):230-5. PMID: 7353345.
      Citations:    
    75. Bjornsson TD, Shand DG. Estimation of kinetic parameters from a two-point determination of the drug cumulation factor. Clin Pharmacol Ther. 1979 Nov; 26(5):540-7. PMID: 498694.
      Citations:    
    76. Bjornsson TD, Meffin PJ, Swezey S, Blaschke TF. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction. J Pharmacol Exp Ther. 1979 Sep; 210(3):316-21. PMID: 480183.
      Citations:    
    77. Routledge PA, Bjornsson TD, Kitchell BB, Shand DG. Heparin administration increases plasma warfarin binding in man. Br J Clin Pharmacol. 1979 Sep; 8(3):281-2. PMID: 497095.
      Citations:    
    78. Bjornsson TD, Meffin PJ, Swezey SE, Blaschke TF. Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1. J Pharmacol Exp Ther. 1979 Sep; 210(3):322-6. PMID: 480184.
      Citations:    
    79. Bjornsson TD, Levy G. Pharmacokinetics of heparin. I. Studies of dose dependence in rats. J Pharmacol Exp Ther. 1979 Aug; 210(2):237-42. PMID: 458630.
      Citations:    
    80. Bjornsson TD, Levy G. Pharmacokinetics of heparin. II. Studies of time dependence in rats. J Pharmacol Exp Ther. 1979 Aug; 210(2):243-6. PMID: 458631.
      Citations:    
    81. Bjornsson TD, Blaschke TF. Vitamin K1 disposition and therapy of warfarin overdose. Lancet. 1978 Oct 14; 2(8094):846-7. PMID: 81403.
      Citations:    
    82. Bjornsson TD, Swezey SE, Meffin PJ, Blaschke TF. Quantitation of radio-labelled vitamin K1 and vitamin K1 epoxide in plasma by high pressure liquid chromatography. Thromb Haemost. 1978 Apr 30; 39(2):466-73. PMID: 580994.
      Citations:    
    83. Richards RK, Bjornsson TD, Waterbury LD. Rise in serum and urine creatinine after phenacemide. Clin Pharmacol Ther. 1978 Apr; 23(4):430-7. PMID: 630790.
      Citations:    
    84. Bjornsson TD, Meffin PJ, Blaschke TF. Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin. J Pharmacokinet Biopharm. 1977 Oct; 5(5):495-505. PMID: 925883.
      Citations:    
    85. Bjornsson TD, Blaschke TF, Meffin PJ. High-pressure liquid chromatographic analysis of drugs in biological fluids. IV. Determination of clofibrinic acid. J Chromatogr. 1977 Jul 11; 137(1):145-52. PMID: 893579.
      Citations:    
    Bjornsson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (386)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _